Showing posts with label Clinical Trials. Show all posts
Showing posts with label Clinical Trials. Show all posts

01 September 2012

Interactive tutorial on clinical trials



Interactive tutorial on clinical trials

U.S. government Web sites provide information about clinical studies, drug development, and other health care issues.

http://www.nlm.nih.gov/medlineplus/tutorials/clinicaltrials/htm/index.htm

Read more...

20 February 2012

Jaundice (Kamala in Ayurveda Manjal Kaamalai in Siddha) Clinical Trials and conditions



Jaundice (Kamala in Ayurveda Manjal Kaamalai in Siddha) Clinical Trials and conditions

Condition: Patients With Obstructive Jaundice

Conditions: Jaundice;   Breastfeeding

Conditions: Obstructive Jaundice;   Disease as Reason for ERCP;   Immune Dysfunction;   Immune

Condition: Jaundice, Neonatal

Conditions: Jaundice Extrahepatic Obstructive;   Disorder of Bile Duct Stent

Condition: Hyperbilirubinemia

Conditions: Hyperbilirubinemia, Neonatal;   Jaundice, Neonatal

Condition: Jaundice, Neonatal

Condition: Biliary Obstruction

Conditions: Hepatocellular Carcinoma;   Obstructive Jaundice

Conditions: Infant, Newborn;   Jaundice

Condition: Biliary Atresia

Conditions: Periampullary Cancers Causing Obstructive Jaundice;   Pancreas Head Cancer;   Bile Duct Cancer;   Carcinoma of Ampulla of Vater

Conditions: Biliary Tract Neoplasms;   Pancreatic Neoplasms;   Jaundice, Obstructive
               
Conditions: Neonatal Hyperbilirubinemia;   Neonatal Jaundice;   Jaundice;   Hyperbilirubinemia

Conditions: ABO Incompatibility;   Hemolytic Disease of Newborn;   Neonatal Jaundice;   Neonatal Hyperbilirubinemia

Conditions: Anemia;   Ferritin;   Complications;   Hemorrhage;   Jaundice

Conditions: Gallbladder Cancer;   Obstructive Jaundice

Conditions: Obstructive Jaundice;   Pancreatic Cancer

Condition: Bile Duct Neoplasms Malignant

Condition: Jaundice

Conditions: Neonatal Jaundice;   Hyperbilirubinemia

Condition: Neonatal Jaundice

Conditions: Hyperbilirubinemia;   Jaundice

Conditions: Biliary Tract Neoplasms;   Jaundice, Obstructive
Interventions: Device: ComVi stent;   Device: Uncovered SEMS
Outcome Measure: Time to stent occlusion

Condition: Jaundice

Condition: Icterus

Conditions: Pancreaticobiliary Cancers;   Jaundice;   Bile Duct Obstruction

Conditions: Acute Viral Hepatitis;   Diabetes Mellitus

Condition: Obstructive Jaundice

Conditions: Ampullary Cancer;   Duodenal Cancer;   Bile Duct Cancer;   Bile Duct Disorders;   Gallstones;   Obstructive Jaundice;   Pancreatic Disorders (Noncancerous);   Colorectal Cancer;   Esophageal Cancer;   Barrett's Esophagus;   Gastric Malignancies;   Pancreatic Cancer;   Pediatric Gastroenterology;   Cholangiocarcinoma;   Pancreatic Pseudocysts;   Acute and Chronic Pancreatitis;   Recurrent Pancreatitis;   Cholangitis;   Bile Leak;   Biliary Strictures;   Pancreatic Divisum;   Biliary and Pancreatic Stones;   Choledocholithiasis



Conditions: Gallbladder Disease;   Gallstones;   Pancreatitis;   Abdominal Pain;   Jaundice


Conditions: Pancreatic Neoplasms;   Biliary Tract Neoplasms;   Duodenal Neoplasms

Conditions: Biliary Tract Neoplasms;   Pancreatic Neoplasms;   Stents

Condition: Hyperbilirubinemia

Condition: Cholangiocarcinoma

Condition: Bile Duct Neoplasms

Condition: Inoperable Tumors of the Bile Duct

Condition: HIV

Condition: HIV Infection


Condition: Hyperbilirubinemia

Conditions: Adenocarcinoma of the Pancreas;   Advanced Solid Tumors;   Cancer;   Cancer of Pancreas;   Cancer of the Pancreas;   Metastases;   Metastatic Cancer;   Metastatic Pancreatic Cancer;   Pancreas Cancer;   Pancreatic Cancer;   Bone Metastases;   Endocrine Cancer;   Oncology;   Oncology Patients;   Solid Tumors;   Advanced Malignancy

Conditions: Iron Deficiency;   Neonatal Hyperbilirubinemia

Condition: Biliary Atresia

Conditions: Cancer of Bile Duct;   Pancreatic Cancer


Condition: Malignant Biliary Strictures
Intervention: Device: Endoscopic retrograde cholangiography (ERC) (ComVi biliary stent)

Condition: Prematurity


Condition: Gallbladder Cancer

Condition: Primary Sclerosing Cholangitis

Condition: Liver Failure

Condition: Biliary Atresia

Conditions: Liver Diseases;   Alagille Syndrome;   Alpha 1-Antitrypsin Deficiency

Condition: Cholangiocarcinoma

Conditions: Biliary Atresia;   Cholestasis

Conditions: Pancreatic Cancer;   Chronic Pancreatitis;   Type II Diabetes;   Pancreatic Cysts;   Control

Condition: Primary Sclerosing Cholangitis

Condition: Iron-Deficiency Anemia


Condition: Toxoplasmosis


Condition: Pancreatic Cancer

Condition: Non-Hodgkin's Lymphoma



Condition: Hepatitis, Toxic

Condition: Type 2 Diabetes

Condition: Biliary Stricture

Condition: HIV

Condition: Malignant Tumor of Extrahepatic Bile Duct

Conditions: Short Bowel Syndrome;   Necrotizing Enterocolitis;   Perforation of Small Intestine

Conditions: Autoimmune Pancytopenia;   Autoimmune Lymphoproliferative Syndrome (ALPS);   Evans

Condition: Gestational Diabetes Mellitus

Conditions: Hyperbilirubinemia;   Erythroblastosis, Fetal

Conditions: Mild Traumatic Brain Injury;   Post-Traumatic Stress Disorder

Condition: Hepatitis B

Condition: Infant Bacterial Meningitis

Condition: Neonatal Hyperbilirubinemia

Condition: Hyperbilirubinemia, Neonatal

Conditions: Acute on Chronic Liver Failure;   Hepatitis B


Condition: Liver Failure

Condition: Liver Cirrhosis

Conditions: Liver Cirrhosis;   Fibrosis;   Liver Disease;   Digestive System Disease

Condition: Liver Cirrhosis

Conditions: Acute Hepatitis A;   Hepatitis

Conditions: Liver Cirrhosis;   Radiology;   Mesenchymal Stem Cells;   Umbilical Cord

Condition: Liver Failure

Read more...

11 February 2012

Current Clinical Trials on Vitiligo / Switra in Ayurveda / Venpadai in Siddha




Current Clinical Trials on Vitiligo (Switra in Ayurveda, Venpadai in Siddha)

  1. HI-Light Pilot Trial for Vitiligo: Hand Held NB-UVB for Early or Focal Vitiligo at Home
  2. Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo
  3. Vitiligo Skin Transplantation
  4. Ginkgo Biloba for the Treatment of Vitiligo Vulgaris in Adolescents
  5. Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis)
  6. Effect of Fluticasone Proprionate 0.05% on Narrow Band UV-B in Active Vitiligo
  7. Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo (NSV)
  8. Clinical Trial of Simvastatin to Treat Generalized Vitiligo
  9. Botulinum Toxin Treatment for Localized Vitiligo
  10. Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo
  11. Punchgrafting Techniques for Vitiligo
  12. Efficacy and Safety of ACH24 in the Treatment of Vitiligo
  13. Treatment of Vitiligo With Low-energy Visible Light Laser
  14. Narrowband UVB Treatment in Patients With Vitiligo
  15. Topical Bimatoprost Solution 0.03%in Stable Vitiligo
  16. Study of Applications of Autologous Epidermal Cells in Liquid Phase in the Treatment of Vitiligo
  17. Epidermal Cell Transplantation in Vitiligo Skin With and Without Narrow-band Ultraviolet B (UVB) Treatment
  18. Comparison of Efficacy and Safety of 0.1% Tacrolimus and 0.1% Mometasone Furoate for Adult Vitiligo
  19. Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo
  20. Questionnaire and Laboratory Data on Vitiligo Vulgaris
  21. Emervel Deep Lidocaine vs. Juvederm® Ultra Plus in Treatment of Moderate to Severe Facial Wrinkles and Folds
  22. Safety Study of Cosmetic Tissue Augmentation in People of Color
  23. Trial for the Evaluation of the Effect of Systemic Low-dose Interleukin-2 (IL-2) on the Immunogenicity of a Vaccine Comprising Synthetic Melanoma Peptides Administered With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With High Risk Melanoma
  24. Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo
  25. A Post-Market Study to Evaluate Adverse Event Incidence Rates in Patients With Skin of Color Undergoing Correction of Nasolabial Folds With Hylaform, Hylaform Plus and Captique.
  26. Assessment of Atrophogenic Potential of Triple Combination Cream for Treatment of Melasma
  27. Post Market Safety Study and Effectiveness With Evolence in Subjects With Skin Color Types IV-VI

Read more...

100 Current clinical trial details on rheumatoid arthritis



100 Current clinical trial details on rheumatoid arthritis
Click on title to view details.



  1. A 3-year Study Following up Patients With Moderate to Severe Rheumatoid Arthritis Treated With Humira in Greece
  2. A Dose Range Finding Study of JNJ-39758979 in Patients With Active Rheumatoid Arthritis Currently Treated With Methotrexate
  3. A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
  4. A Pilot Study of Potassium Supplementation for Adult Patients With Rheumatoid Arthritis
  5. A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis
  6. A Study Comparing CRx-102 Plus Disease-Modifying Anti-Rheumatic Drug (DMARD) Therapy to Placebo Plus DMARD Therapy in Rheumatoid Arthritis
  7. A Study Evaluating the Safety and Efficacy of Cura-100 in Subjects With Rheumatoid Arthritis and Osteoarthritis
  8. A Study Exploring the Safety, Tolerability and Efficacy of a 4 Week Course of INCB018424 in Subjects With Active Rheumatoid Arthritis
  9. A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
  10. A Study Of PF-04171327 In The Treatment Of The Signs And Symptoms Of Rheumatoid Arthritis
  11. A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Juvenile Rheumatoid Arthritis
  12. A Study of the Safety and Effectiveness of Lyophilized Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
  13. A Study of the Safety of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
  14. A Study on the Prevalence of the Anti-MCV Anti-body in an Irish Rheumatoid Arthritis (RA) Population and the Impact of Biomarker Status on the Management of Irish Patients With Early RA
  15. A Study to Evaluate the RNA Signature of Rheumatoid Arthritis From Synovium and Whole Blood
  16. A Trial to Evaluate the Safety and Tolerability of MT203 in Patients With Mild to Moderate Rheumatoid Arthritis
  17. Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis
  18. Assessment of Body Image in Patients With Rheumatoid Arthritis
  19. Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With Adalimumab
  20. Atherosclerosis in Rheumatoid Arthritis
  21. Clinically Important Changes in Rheumatoid Arthritis
  22. Cognitive Behavioral Therapy Treatments for Adults With Rheumatoid Arthritis (The SARA Study)
  23. Coping Skills Training for Early Rheumatoid Arthritis
  24. Cost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthritis (RA)
  25. Diagnostic Value of Oral Prednisolone Test for Rheumatoid Arthritis
  26. Effects Of CP-690,550 (Tasocitinib) On Cholesterol Metabolism In Patients With Active Rheumatoid Arthritis
  27. Effects of Tranilast on Pharmacokinetics of Methotrexate (MTX) in Patients With Rheumatoid Arthritis (RA)
  28.  Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate.
  29. Efficacy and Safety of Adalimumab in Patients With Rheumatoid Arthritis in Routine Clinical Practice
  30. Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drug (DMARD)-Naïve Adults With Early Active Rheumatoid Arthritis
  31. Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drug (DMARD)-Naïve Adults With Early Active Rheumatoid Arthritis
  32. Efficacy of Oncoxin Plus Viusid in the Treatment of Rheumatoid Arthritis
  33. Evaluation of EULAR-RAID Score in Rheumatoid Arthritis Patients
  34. Evaluation of the Role of Adalimumab on Extraarticular Manifestation - Bone Metabolism and Bone Mineral Density in Patients With Active Rheumatoid Arthritis
  35. Exploratory Trial to Evaluate Premature Endothelial Dysfunction in Early Rheumatoid Arthritis(RA)Compared to Patients With Established RA, and Normal Subjects
  36. Genetic and Immune Studies of Rheumatoid Arthritis and Related Conditions
  37. Genetics of Rheumatoid Arthritis
  38. Health Outcomes in Rheumatoid Arthritis
  39. Humira in Rheumatoid Arthritis - Do Bone Erosions Heal?
  40. Hydroxychloroquine to Improve Insulin Sensitivity in Rheumatoid Arthritis
  41. Identification of Genes Associated With Lung Disease in Patients With Rheumatoid Arthritis
  42. Inflammation and Insulin Resistance in Rheumatoid Arthritis
  43. Infliximab for the Treatment of Early Rheumatoid Arthritis
  44. Infliximab to Treat Children With Juvenile Rheumatoid Arthritis
  45. Interest of a Standardized Monitoring of Rheumatoid Arthritis: The COMEDRA Trial
  46. Iyengar Yoga for Young People With Rheumatoid Arthritis
  47. Low Density Lipoprotein Cholesterol (CLDL) as a Cardiovascular Disease Risk Factor in Rheumatoid Arthritis
  48. Lung Disease Associated With Rheumatoid Arthritis
  49. Magnetic Resonance Image Verified Early Response to Certolizumab Pegol in Subjects With Active Rheumatoid Arthritis (RA)
  50. Meditation-Based Stress Reduction in Rheumatoid Arthritis
  51. Moderate Rheumatoid Arthritis (RA) With Enbrel
  52. Monitoring Epstein-Barr Virus (EBV) Load in Rheumatoid Arthritis Patients Treated With New Immunosuppressive Drugs
  53. Open Label Study to Assess the Predictability of Early Response to Certolizumab Pegol in Patients With Rheumatoid Arthritis
  54. Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to Etanercept
  55. Orally Active, Small Molecule Inhibitor of MEK1 and MEK2 in Patients With Active Rheumatoid Arthritis
  56. Patient Rheumatoid Arthritis Social Support Study
  57. Phase II Study Evaluating the Safety and Efficacy of GSK315234 in Patients With Rheumatoid Arthritis
  58. Physical Activity Behavior of Rheumatoid Arthritis Patients and Healthy Controls
  59. Positron Emission Tomography and Magnetic Resonance Imaging to Evaluate Synovial Blood Flow in Rheumatoid Arthritis Patients
  60. PPAR-gamma Agonists, Rheumatoid Arthritis and Cardiovascular Disease
  61. Relaxation Response Training for the Treatment of Rheumatoid Arthritis
  62. Rheumatoid Arthritis (DMARD) Intervention and UtilizationStudy
  63. Rheumatoid Arthritis Disease Activity Monitor
  64. Rheumatoid Arthritis DMARD Intervention and UtilizationStudy
  65. Rheumatoid Arthritis: Comparison of Active Therapies in Patients With Active Disease Despite Methotrexate Therapy
  66. Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA)
  67. Rosuvastatin in Rheumatoid Arthritis (RORA)
  68. Safety and Effect on Quality of Life/Work Productivity of Humira in Patients With Rheumatoid Arthritis
  69.  Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid Arthritis
  70.  Safety and Effectiveness of Infliximab in Slovakia When Used for Rheumatoid Arthritis (Study P04741)(COMPLETED)
  71. Safety and Efficacy of ACZ885 in Adult Patients With Established Rheumatoid Arthritis
  72. Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid Arthritis
  73. Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis
  74. Safety Study of SCIO-469 to Treat Patients With Active Rheumatoid Arthritis Receiving Methotrexate
  75. Serum Concentration of Adalimumab as a Predictive Factor of Clinical Outcomes in Rheumatoid Arthritis (AFORA)
  76. Special Investigation in Patients With Rheumatoid Arthritis (Working Productivity Activity Impairment)
  77. Specimen Collection for Individuals With Lung Disease Associated With Rheumatoid Arthritis
  78. Standard Disease Activity Parameters and Step Activity in Patients With Rheumatoid Arthritis Receiving Etanercept
  79. Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis
  80. Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate Therapy
  81. Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg
  82. Study Evaluating Enbrel in Patients With Rheumatoid Arthritis
  83. Study Evaluating Single Doses Of SBI-087 in Subjects With Rheumatoid Arthritis
  84. Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
  85. Study of Enbrel in Rheumatoid Arthritis (RA) Subjects With Comorbid Disorders
  86. Study of Human Leukocyte Antigen (HLA) Polymorphisms in Patients With Rheumatoid Arthritis
  87. Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis
  88. Targeting Synovitis in Early Rheumatoid Arthritis
  89. The Controlled Trial of Apremilast for Rheumatoid Arthritis Treatment (CARAT)
  90. The Relation Between Dedicated Extremity MRI Synovitis and Structural Deterioration Radiographic in Patients With Rheumatoid Arthritis in Clinical Remission. Preliminary Study
  91. The Role of Cytokines on Growth Hormone Suppression in Premenopausal Women With Rheumatoid Arthritis and the Effect of Treatment With Etanercept
  92. The Use of Anti-CD4 Monoclonal Antibody (mAb)-Fragment for the Imaging of Chronic Inflammation in Patients With Active Rheumatoid Arthritis
  93. Time to DMARD (Disease-Modifying Anti-Rheumatic Drug) Treatment and Actual Work Limitation of Patients With Rheumatoid Arthritis in Turkey
  94. TIV and High Dose TIV in Subjects With Rheumatoid Arthritis
  95. Treating Rheumatoid Arthritis With Tripterygium Wilfordi Hook F or Sulfasalazine
  96. Treatment of Hypovitaminosis D in Rheumatoid Arthritis
  97. Treatment of Vitamin D Deficiency in Patients With Rheumatoid Arthritis
  98. Ultrasonography as a Biomarker in Early Rheumatoid Arthritis
  99. Ultrasound Scores as Indication of Response to Subcutaneous Abatacept in Subjects With Rheumatoid Arthritis
  100. Zostavax in Rheumatoid Arthritis

Read more...
All links posted here are collected from various websites. No video or powerpoint files are uploaded on this blog. If you are the original author and do not wish to display your content on this blog please Email me anandkumarreddy at gmail dot com I will remove it. The contents of this blog are meant for educational purpose and not for commercial use. If you use any content give due credit to the original author.

This site uses cookies from Google to deliver its services, to personalise ads and to analyse traffic. Information about your use of this site is shared with Google. By using this site, you agree to its use of cookies.

  © Blogger templates Newspaper III by Ourblogtemplates.com 2008

Back to TOP